Cuadra, Emie Flor T.
HRN: 12-05-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2023
CEFUROXIME 750MG (VIAL)
02/28/2023
03/07/2023
IVT
750mg
Q8
UTI; Pus Cells: 15-20; Bacteria: Moderate
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Non-compliant To Guidelines